NOW AVAILABLE: THE AMP SCZ DATA RELEASE 2.0
The AMP SCZ Data Release 2.0 is now available. Find out how researchers with an approved NDA Data Use Certification may obtain it.
Learn More
AMP SCZ Brain Waves™ Interview
On One Mind's Brain Waves™ podcast, One Mind President, Brandon Staglin, hosted a conversation with Dr. Joshua Gordon, Director of the National Institute of Mental Health, and Carlos Larrauri, Co-Chair of the AMP-SCZ Steering Committee.
Watch Now
Clinical High Risk for Psychosis
Young people may start to show signs of risk for psychosis months or even years before they receive a diagnosis. Learn about these signs and why early treatment is important.
Read More
The AMP SCZ Approach
The aims of this global effort include developing tools that identify the early stages of risk for schizophrenia and predicting the likelihood of progression to psychosis and other outcomes.
Read MoreLatest News
Groundbreaking study shows promise for early detection and intervention in psychotic disorders such as schizophrenia Messiah or pariah? Psychosis, science, and finding meaning in lived experience Celebrating Ten Years of Breakthroughs: The Accelerating Medicines Partnership® Program White House Shares Government, Private Sector, Academic, and Non-Profit Actions to Accelerate Progress on Mental Health Research AMP® Symposium Day 2: Schizophrenia Health Matters: Mental Health Edition--Evaluating Psychosis and Schizophrenia Read More
About
The Accelerating Medicines Partnership (AMP®) program is a public-private partnership between the National Institutes of Health, the U.S. Food and Drug Administration, the European Medicines Agency, pharmaceutical and life science companies, non-profit and other organizations. The AMP Schizophrenia (SCZ) program was launched in 2020 to address the critical need for more effective treatments for people with schizophrenia and related mental health conditions.
Read More
Study Sites
The AMP SCZ program consists of a coordination center and two research networks of 43 study sites across the globe.
Explore Locations
Frequently Asked Questions
If you or a family member has been invited to participate in this study, you probably have lots of questions. Review our frequently asked questions to get the answers you are looking for.
What is clinical research? What are some reasons to participate in research? I don't have schizophrenia. Can I still participate? What happens after the study? Read More